Syneron Medical Ltd (NASDAQ:ELOS)
| 8.69 Data as of May 24 |  -0.11 / -1.25%Today’s Change | 7.21 Today|||52-Week Range 11.15 | +0.23% Year-to-Date |
Latest ELOS News | Press Releases
| Syneron Medical Hits Estimates in Solid Quarter May 22 / MotleyFool.com | Does The Street Have Syneron Medical Figured Out? May 17 / MotleyFool.com |
Today’s Trading
| Previous close | 8.80 |
| Today’s open | 8.75 |
| Day’s range | 8.65 - 8.89 |
| Volume | 104,402 |
| Average volume (3 months) | 128,249 |
| Market cap | $313.5M |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/24/2013
Growth & Valuation
| Earnings growth (last year) | +97.22% |
| Earnings growth (this year) | +387.50% |
| Earnings growth (next 5 years) | +34.00% |
| Revenue growth (last year) | +15.46% |
| P/E ratio | 5.4 |
| Price/Sales | 1.17 |
| Price/Book | 1.41 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| DEPODepomed Inc | +0.10 | +1.73% |
| UNISUnilife Corp | -0.05 | -1.29% |
| CERSCerus Corp | +0.04 | +0.78% |
| ANGOAngioDynamics Inc | +0.04 | +0.37% |
Data as of 4:00pm ET, 05/24/2013
Financials
| Last reporting date | May 22, 2013 |
| EPS forecast (this quarter) | -$0.10 |
| Annual revenue (last year) | $263.6M |
| Annual profit (last year) | -$1.3M |
| Net profit margin | -0.51% |
Profile
Sector Health Technology |
Industry Medical Specialties |
Chief Executive Officer Shimon Eckhouse, PhD |
President Amit Meridor, MBA |
Corporate headquarters Yokneam Illit, -- |
Forecasts
